 6. Patients have a history of baseline medication with methotrexate MTX or other DMARDs drugs leflunomide, hydroxychloroquine, iguratimod, sulfasalazine, tripterygium Glycosides for 3 months, but couldnt achieve clinical remission or low disease activity; or couldnt tolerate one or more DMARDs, and DAS283.2; 